Royal Bank of Canada filed a free writing prospectus on November 18, 2026, disclosing terms for Auto-Callable Contingent Coupon Barrier Notes linked to the common stock of Bristol-Myers Squibb Company, due November 30, 2029.

Key Highlights

  • Underlier: The common stock of Bristol-Myers Squibb Company (Bloomberg symbol "BMY UN")
  • Contingent Coupon: At least $26.25 per $1,000 principal amount per quarter, corresponding to a rate of at least 2.625% per quarter or at least 10.50% per annum, to be determined on the Trade Date
  • Barrier and Coupon Threshold: Both set at 70% of the Initial Underlier Value
  • Maturity Date: November 30, 2029, with a Valuation Date of November 27, 2029
  • Initial Estimated Value: Expected to be between $903.50 and $953.50 per $1,000 principal amount, less than the public offering price
  • CUSIP: 78018DT56, issued under Registration Statement No. 333-275898

Terms and Structure of the Bristol-Myers Squibb-Linked Notes

According to the filing, Royal Bank of Canada (NYSE:RY) is the issuer of the Notes, with a Trade Date of November 25, 2026, and an Issue Date of November 30, 2026. The Notes are linked to the closing value of Bristol-Myers Squibb Company common stock. The filing discloses that investors will receive a Contingent Coupon on a quarterly Coupon Payment Date only if the closing value of the underlier is greater than or equal to the Coupon Threshold on the immediately preceding Coupon Observation Date. The filing also describes a memory feature: a Contingent Coupon not paid on one date may be paid on a later Coupon Payment Date if conditions are then met.

The filing states that the Notes are subject to automatic call on a quarterly basis beginning approximately six months following the Trade Date. If the closing value of the underlier on any Call Observation Date is greater than or equal to the Initial Underlier Value, the Notes will be called at $1,000 per $1,000 principal amount plus any Contingent Coupon and unpaid Contingent Coupons otherwise due. If the Notes are not called and the Final Underlier Value at maturity is greater than or equal to the Barrier Value (70% of the Initial Underlier Value), investors receive their principal plus applicable coupons. The filing warns: "If the Notes are not automatically called and the Final Underlier Value is less than the Barrier Value, you will lose a substantial portion or all of your principal amount at maturity."

The filing states that the initial estimated value is expected to be between $903.50 and $953.50 per $1,000 principal amount and "will be less than the public offering price of the Notes." The filing lists multiple risk factors, including that investors may not receive any Contingent Coupons, will not participate in any appreciation of the underlier, and that payments are subject to Royal Bank of Canada's credit risk. The filing notes that U.S. federal income tax consequences are uncertain and that there may not be an active trading market for the Notes.

What Was Disclosed

Royal Bank of Canada filed a free writing prospectus describing the key terms, payment mechanics, barrier and coupon threshold levels, initial estimated value range, and risk considerations for Auto-Callable Contingent Coupon Barrier Notes linked to Bristol-Myers Squibb common stock, maturing November 30, 2029.